INCR241115P2500
- 1.03
- 0.000.00%
InterCure Newsroom
AP Reports Florida Voters Reject Cannabis Legalization; Amendment 3 Did Not Secure 60% Of Vote
Microsoft Shares Are Trading Higher After the Company Reported Better-than-expected Q1 2025 GAAP EPS and Sales.
Banzai Granted Extension By Nasdaq Hearing Panel To Regain Compliance With Listing Requirements
InterCure | 6-K/A: Report of foreign private issuer (related to financial reporting)
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
Intercure Shares Are Trading Higher. The Company Reported H1 Financial Results.
InterCure: 1H Revenue Hurt by Oct. 7 Terrorist Attack, War in Gaza >INCR
Press Release: InterCure Announces First Half of 2024 Results: Revenue of NIS 126 Million and Adjusted EBITDA of NIS 21 Million
InterCure | 6-K: Report of foreign private issuer (related to financial reporting)
InterCure Expands Strategic Partnership With Cookies to Germany
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon
Industry Report: The Cannabis Company That Soared Nearly 100% This Year: What's Behind InterCure's Surge
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
Leading Analyst Gives InterCure Overweight Rating, Noting 5x Returns Potential
Intercure Ltd. Files SEC Report, Ensures Transparency
InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference
InterCure Reports FY Results
Intercure Ltd. Files April SEC Report
Press Release: InterCure Announces FY2023 Results: Revenue of NIS 356 Million and Adjusted EBITDA of NIS 61 Million